The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines

被引:333
作者
Kim, JI
Ho, IC
Grusby, MJ
Glimcher, LH
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
关键词
D O I
10.1016/S1074-7613(00)80073-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-4 promotes the differentiation of naive CD4(+) T cells into IL-4-producing T helper 2 (Th2) cells. Previous work provided suggestive but not conclusive evidence that the transcription factor c-Maf directed the tissue-specific expression of IL-4. It was not known whether c-Maf controlled the transcription of other Th2 cytokine genes. To elucidate the role of c-Maf in vivo, we examined cytokine production in mice lacking c-Maf (c-maf(-/-)). CD4(+) T cells and NK T cells from c-maf(-/-) mice were markedly deficient in IL-4 production. However, the mice produced normal levels of IL-13 and IgE, and, when differentiated in the presence of exogenous IL-4, c-maf(-/-) T cells produced approximately normal levels of other Th2 cytokines. We conclude that c-Maf has a critical and selective function in IL-4 gene transcription in vivo.
引用
收藏
页码:745 / 751
页数:7
相关论文
共 50 条
  • [1] AN INTERLEUKIN-4 (IL-4) MUTANT PROTEIN INHIBITS BOTH IL-4 OR IL-13-INDUCED HUMAN IMMUNOGLOBULIN-G4 (IGG4) AND IGE SYNTHESIS AND B-CELL PROLIFERATION - SUPPORT FOR A COMMON COMPONENT SHARED BY IL-4 AND IL-13 RECEPTORS
    AVERSA, G
    PUNNONEN, J
    COCKS, BG
    MALEFYT, RD
    VEGA, F
    ZURAWSKI, SM
    ZURAWSKI, G
    DEVRIES, JE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) : 2213 - 2218
  • [2] Differences between IL-4Rα-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses
    Barner, M
    Mohrs, M
    Brombacher, F
    Kopf, M
    [J]. CURRENT BIOLOGY, 1998, 8 (11) : 669 - 672
  • [3] Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1T cells
    Bendelac, A
    Hunziker, RD
    Lantz, O
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) : 1285 - 1293
  • [4] In vivo treatment with anti-interleukin-13 antibodies significantly reduces the humoral immune response against an oral immunogen in mice
    Bost, KL
    Holton, RH
    Cain, TK
    Clements, JD
    [J]. IMMUNOLOGY, 1996, 87 (04) : 633 - 641
  • [5] beta 2-microglobulin-dependent NK1.1(+) T cells are not essential for T helper cell 2 immune responses
    Brown, DR
    Fowell, DJ
    Corry, DB
    Wynn, TA
    Moskowitz, NH
    Cheever, AW
    Locksley, RM
    Reiner, SL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) : 1295 - 1304
  • [6] BROWN KD, 1989, J IMMUNOL, V142, P679
  • [7] Chiaramonte MG, 1999, J IMMUNOL, V162, P920
  • [8] Cohn L, 1998, J IMMUNOL, V161, P3813
  • [9] Csonga R, 1998, J IMMUNOL, V160, P273
  • [10] INTERLEUKIN-13 IS A B-CELL STIMULATING FACTOR
    DEFRANCE, T
    CARAYON, P
    BILLIAN, G
    GUILLEMOT, JC
    MINTY, A
    CAPUT, D
    FERRARA, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (01) : 135 - 143